Results 161 to 170 of about 3,789 (186)

Current and Future Treatment Options for Cerebral Cavernous Malformations. [PDF]

open access: yesStroke Vasc Interv Neurol
Morrison L   +7 more
europepmc   +1 more source

Role of Rho-Associated Kinase in the Pathophysiology of Cerebral Cavernous Malformations. [PDF]

open access: yesNeurol Genet
Ayata C   +8 more
europepmc   +1 more source

Somatic Genetic Testing Provides Diagnosis of Verrucous Venous Malformation in an Individual with Discrepant Radiology, Pathology, and Clinical Findings. [PDF]

open access: yesJ Vasc Anom (Phila)
Britt A   +9 more
europepmc   +1 more source

Novel CCM2 missense variants abrogating the CCM1–CCM2 interaction cause cerebral cavernous malformations

Journal of Medical Genetics, 2020
Background Cerebral cavernous malformations (CCMs) are vascular malformations mostly located within the central nervous system. Most deleterious variants are loss of function mutations in one of the three CCM genes. These genes code for proteins that form a ternary cytosolic complex with CCM2 as a hub. Very few CCM2
Bergametti, Françoise   +12 more
openaire   +3 more sources

Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex

Human Mutation, 2008
Cerebral cavernous malformations (CCM) are prevalent cerebrovascular lesions predisposing to chronic headaches, epilepsy, and hemorrhagic stroke. Using a combination of direct sequencing and MLPA analyses, we identified 15 novel and eight previously published CCM1 (KRIT1), CCM2, and CCM3 (PDCD10) mutations.
Stahl, S   +16 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy